Alto Neuroscience
Alto Neuroscience33
About
What does Alto Neuroscience do?
Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing a new generation of precision psychiatry medicines. They use an AI-enabled platform to identify and validate brain-based biomarkers, aiming to match patients with the right Alto drug candidate for depression, PTSD, and other mental health disorders.
What is Alto Neuroscience's revenue?
StartupHub estimates Alto Neuroscience's annual revenue at $17.7M (range $10.2M to $42.9M, 65% confidence), based on comparable companies in the sector.
What is Alto Neuroscience's valuation?
StartupHub estimates Alto Neuroscience's effective valuation at $1.3B (range $925.0M to $2.2B, 22% confidence), based on comparable companies in the sector.
How much funding has Alto Neuroscience raised?
Alto Neuroscience has raised a total of $370M in funding. The most recent round on record is Registered Direct Offering.
Where is Alto Neuroscience headquartered?
Alto Neuroscience is headquartered in Los Altos, United States.
When was Alto Neuroscience founded?
Alto Neuroscience was founded in 2019.
What industry does Alto Neuroscience operate in?
Alto Neuroscience operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Mental Health Tech.
How many employees does Alto Neuroscience have?
Alto Neuroscience has approximately 86 people on record.
No comments yet. Be the first to share your take.